TY - JOUR
AU - J. Sibbesen
AU - M. A. Abate
AU - Z. Dai
AU - G. S. Smith
AU - E. Lundstrom
AU - J. C. Kraner
AU - A. R. Mock
A1 - 
AD - Department of Clinical Pharmacy, School of Pharmacy, West Virginia University, West Virginia, Morgantown, USA.; Health Affairs Institute, West Virginia University, Morgantown, West Virginia, USA.; Department of Epidemiology and Biostatistics, School of Public Health, West Virginia University, West Virginia, Morgantown, USA.; West Virginia Department of Health and Human Resources, West Virginia Office of the Chief Medical Examiner, Charleston, West Virginia, USA.
AN - 36504413
BT - Am J Addict
C5 - Opioids & Substance Use; Healthcare Disparities
CP - 3
DA - May
DO - 10.1111/ajad.13365
DP - NLM
ET - 20221212
IS - 3
JF - Am J Addict
LA - eng
PY - 2023
SN - 1055-0496 (Print); 1055-0496
SP - 309
EP - 313+
ST - Characteristics of xylazine-related deaths in West Virginia-Xylazine-related deaths
T1 - Characteristics of xylazine-related deaths in West Virginia-Xylazine-related deaths
T2 - Am J Addict
TI - Characteristics of xylazine-related deaths in West Virginia-Xylazine-related deaths
U1 - Opioids & Substance Use; Healthcare Disparities
U3 - 10.1111/ajad.13365
VL - 32
VO - 1055-0496 (Print); 1055-0496
Y1 - 2023
ER -